$SNWV
SANUWAVE Health, Inc.

2022 Q4 Form 10-Q Financial Statement

#000114036122041447 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $5.500M $4.166M $3.725M
YoY Change 29.11% 11.84% 89.38%
Cost Of Revenue $1.741M $606.0K $1.555M
YoY Change 31.1% -61.03% 183.55%
Gross Profit $3.759M $3.560M $2.170M
YoY Change 28.21% 64.06% 52.98%
Gross Profit Margin 68.35% 85.45% 58.26%
Selling, General & Admin $6.511M $5.054M $5.208M
YoY Change 50.13% -2.96% -18.98%
% of Gross Profit 173.21% 141.97% 240.0%
Research & Development $73.00K $157.0K $297.0K
YoY Change -58.99% -47.14% -31.27%
% of Gross Profit 1.94% 4.41% 13.69%
Depreciation & Amortization $191.0K $587.0K $420.0K
YoY Change -28.2% 39.76% 28.39%
% of Gross Profit 5.08% 16.49% 19.35%
Operating Expenses $6.775M $5.400M $5.505M
YoY Change 27.85% -1.91% -23.41%
Operating Profit -$3.016M -$1.840M -$3.335M
YoY Change 27.42% -44.83% -47.64%
Interest Expense -$4.329M $1.513M -$283.0K
YoY Change -36.64% -634.63% -95.55%
% of Operating Profit
Other Income/Expense, Net $1.427M $0.00
YoY Change -100.0%
Pretax Income -$8.156M -$413.0K -$4.246M
YoY Change -13.74% -90.27% -66.4%
Income Tax $2.000K $0.00 $6.000K
% Of Pretax Income
Net Earnings -$8.158M -$413.0K -$4.252M
YoY Change -13.72% -90.29% -66.36%
Net Earnings / Revenue -148.33% -9.91% -114.15%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share -$0.01 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 548.7M 548.7M 518.3M
Diluted Shares Outstanding 561.1M 518.3M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.153M $1.112M $327.0K
YoY Change 86.27% 240.06% -93.93%
Cash & Equivalents $1.153M $1.112M $327.0K
Short-Term Investments
Other Short-Term Assets $570.0K $1.935M $426.0K
YoY Change 74.85% 354.23% -32.14%
Inventory $868.0K $1.413M $1.526M
Prepaid Expenses
Receivables $4.029M $2.403M $2.417M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.620M $6.863M $4.696M
YoY Change 50.45% 46.15% -52.83%
LONG-TERM ASSETS
Property, Plant & Equipment $750.0K $673.0K $1.091M
YoY Change -32.92% -38.31% 11.36%
Goodwill $7.260M $7.260M
YoY Change 0.0%
Intangibles $5.137M
YoY Change
Long-Term Investments
YoY Change
Other Assets $106.0K $118.0K
YoY Change 0.0% 280.52%
Total Long-Term Assets $13.25M $13.25M $14.49M
YoY Change -6.79% -8.56% -36.77%
TOTAL ASSETS
Total Short-Term Assets $6.620M $6.863M $4.696M
Total Long-Term Assets $13.25M $13.25M $14.49M
Total Assets $19.87M $20.11M $19.18M
YoY Change 6.74% 4.83% -41.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.400M $5.055M $7.069M
YoY Change -42.44% -28.49% 204.41%
Accrued Expenses $8.512M $4.100M $4.178M
YoY Change 93.72% -1.87% 160.55%
Deferred Revenue $60.00K $249.0K $40.00K
YoY Change 25.0% 522.5% -38.5%
Short-Term Debt $14.42M $32.00M $11.36M
YoY Change 181.73%
Long-Term Debt Due $24.12M $14.55M $23.23M
YoY Change -4.98% -37.39% 454.83%
Total Short-Term Liabilities $60.19M $52.47M $47.31M
YoY Change 6.97% 10.91% 139.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $942.0K
YoY Change -100.0% -100.0% -91.34%
Other Long-Term Liabilities $668.0K $468.0K $327.0K
YoY Change 98.22% 43.12% 21.86%
Total Long-Term Liabilities $696.0K $496.0K $942.0K
YoY Change -47.03% -47.35% -93.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.19M $52.47M $47.31M
Total Long-Term Liabilities $696.0K $496.0K $942.0K
Total Liabilities $60.88M $52.96M $48.69M
YoY Change 5.74% 8.78% 44.3%
SHAREHOLDERS EQUITY
Retained Earnings -$194.2M -$186.1M
YoY Change 5.6%
Common Stock $549.0K $549.0K
YoY Change 13.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$41.01M -$32.85M -$29.50M
YoY Change
Total Liabilities & Shareholders Equity $19.87M $20.11M $19.18M
YoY Change 6.74% 4.83% -41.64%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$8.158M -$413.0K -$4.252M
YoY Change -13.72% -90.29% -66.36%
Depreciation, Depletion And Amortization $191.0K $587.0K $420.0K
YoY Change -28.2% 39.76% 28.39%
Cash From Operating Activities -$3.993M -$7.975M -$1.257M
YoY Change -4216.49% 534.45% -76.14%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$164.0K
YoY Change -100.0% 378.41%
Acquisitions
YoY Change
Other Investing Activities -$690.0K $74.00K $0.00
YoY Change -100.0%
Cash From Investing Activities -$690.0K $74.00K -$164.0K
YoY Change 684.09% -145.12% -99.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.720M 7.560M 1.525M
YoY Change 1943.29% 395.74% -94.77%
NET CHANGE
Cash From Operating Activities -3.993M -7.975M -1.257M
Cash From Investing Activities -690.0K 74.00K -164.0K
Cash From Financing Activities 4.720M 7.560M 1.525M
Net Change In Cash 37.00K -341.0K 104.0K
YoY Change -84.58% -427.88% -97.9%
FREE CASH FLOW
Cash From Operating Activities -$3.993M -$7.975M -$1.257M
Capital Expenditures $0.00 -$164.0K
Free Cash Flow -$7.975M -$1.093M
YoY Change 629.64% -79.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
snwv Interest Payable Related Parties
InterestPayableRelatedParties
168000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-473000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
885000
CY2020Q3 snwv Number Of Energy Transfer Technology Products
NumberOfEnergyTransferTechnologyProducts
2
CY2020Q3 snwv Number Of Human Tissues Biological Products
NumberOfHumanTissuesBiologicalProducts
2
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1000
CY2022Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5313000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
888000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
snwv Stock Issued During Period Value Cashless Warrant Exercises
StockIssuedDuringPeriodValueCashlessWarrantExercises
2166000
snwv Stock Issued During Period Warrants Exercised Value
StockIssuedDuringPeriodWarrantsExercisedValue
100000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3720000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-297000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
460000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
690000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
snwv Embedded Conversion Option With Issuances Of Convertible Debt
EmbeddedConversionOptionWithIssuancesOfConvertibleDebt
2309000
snwv Warrant Issuance In Conjunction With Convertible Notes
WarrantIssuanceInConjunctionWithConvertibleNotes
1463000
snwv Warrant Issuance In Conjunction With Convertible Notes
WarrantIssuanceInConjunctionWithConvertibleNotes
758000
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
0
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
204883
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.2
CY2021Q4 snwv Warrant Liability Warrants Outstanding
WarrantLiabilityWarrantsOutstanding
62617188
CY2021Q4 snwv Warrant Liability Fair Value Per Share
WarrantLiabilityFairValuePerShare
0.15
CY2021Q4 snwv Warrant Liability Fair Value
WarrantLiabilityFairValue
9614000
snwv Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
829553984
snwv Class Of Warrant Or Right Issued Per Share
ClassOfWarrantOrRightIssuedPerShare
0.01
snwv Class Of Warrant Or Right Issued Amount
ClassOfWarrantOrRightIssuedAmount
4885000
snwv Gain On Remeasurement Of Warrant Liability
GainOnRemeasurementOfWarrantLiability
0
snwv Loss Gain On Warrant Liability
LossGainOnWarrantLiability
10173000
CY2022Q3 snwv Warrant Liability Warrants Outstanding
WarrantLiabilityWarrantsOutstanding
865134134
CY2022Q3 snwv Warrant Liability Fair Value Per Share
WarrantLiabilityFairValuePerShare
0
CY2022Q3 snwv Warrant Liability Fair Value
WarrantLiabilityFairValue
1196000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001417663
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52985
dei Entity Registrant Name
EntityRegistrantName
SANUWAVE Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1176000
dei Entity Address Address Line1
EntityAddressAddressLine1
11495 Valley View Road
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address City Or Town
EntityAddressCityOrTown
Eden Prairie
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55344
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
419-7525
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
548737651
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
800000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
800000
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5841000
CY2022Q3 snwv Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
4000000
CY2021Q4 snwv Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
11601000
CY2022Q3 snwv Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
1373000
CY2021Q4 snwv Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
1596000
CY2022Q3 snwv Advances On Future Cash Receipts
AdvancesOnFutureCashReceipts
194000
CY2021Q4 snwv Advances On Future Cash Receipts
AdvancesOnFutureCashReceipts
446000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3792000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4247000
CY2022Q3 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
0
CY2021Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
158000
CY2022Q3 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
0
CY2021Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
875000
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2021Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
690000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3301000
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1781000
us-gaap Interest Expense Debt
InterestExpenseDebt
9203000
us-gaap Interest Expense Debt
InterestExpenseDebt
4340000
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
439000
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
55000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
551000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
150000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-86000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
460000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-297000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
460000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
561069625
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
561069625
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518310781
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
518310781
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
542484779
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
542484779
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518370156
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
518370156
CY2022Q3 snwv Shares Issued For Settlement Of Debt And Warrants
SharesIssuedForSettlementOfDebtAndWarrants
1361000
snwv Shares Issued For Settlement Of Debt And Warrants
SharesIssuedForSettlementOfDebtAndWarrants
1361000
snwv Stock Issued During Period Value Reclassification Of Warrant Liability Due To Cashless Warrant Exercise
StockIssuedDuringPeriodValueReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise
2030000
snwv Interest Payable Related Parties
InterestPayableRelatedParties
150000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
640000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
125000
snwv Proceeds From Factoring
ProceedsFromFactoring
-227000
snwv Proceeds From Factoring
ProceedsFromFactoring
1244000
snwv Proceeds From Small Business Administration Ssba Loan
ProceedsFromSmallBusinessAdministrationSSBALoan
0
snwv Proceeds From Small Business Administration Ssba Loan
ProceedsFromSmallBusinessAdministrationSSBALoan
1033000
snwv Settlement Of Debt And Warrants With Stock
SettlementOfDebtAndWarrantsWithStock
1361000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
12366000
snwv Settlement Of Debt And Warrants With Stock
SettlementOfDebtAndWarrantsWithStock
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1928000
snwv Embedded Conversion Option With Issuances Of Convertible Debt
EmbeddedConversionOptionWithIssuancesOfConvertibleDebt
2740000
us-gaap Repayments Of Debt
RepaymentsOfDebt
2981000
us-gaap Repayments Of Debt
RepaymentsOfDebt
237000
snwv Working Capital Balances Refinanced Into Convertible Notes Payable
WorkingCapitalBalancesRefinancedIntoConvertibleNotesPayable
2273000
snwv Working Capital Balances Refinanced Into Convertible Notes Payable
WorkingCapitalBalancesRefinancedIntoConvertibleNotesPayable
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; font-style: italic;">Estimates</span> – These condensed consolidated financial statements have been prepared in accordance with U.S. GAAP. Because a precise determination of assets and liabilities, and correspondingly revenues and expenses, depend on future events, the preparation of condensed consolidated financial statements for any period necessarily involves the use of estimates and assumptions. Actual amounts may differ from these estimates. These condensed consolidated financial statements have, in management’s opinion, been properly prepared within reasonable limits of materiality and within the framework of the accounting policies summarized herein.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Significant estimates include the recording of allowances for doubtful accounts, the net realizable value of inventory, useful lives of long-lived assets, fair value of goodwill and other intangible assets, the determination of the valuation allowances for deferred taxes, estimated fair value of stock-based compensation, and the estimated fair value of financial instruments, including warrants and embedded conversion options.</div>
snwv Class Of Warrant Or Right Weighted Average Exercise Price Of Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceOfExercised
0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
561070000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518311000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
542485000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518370000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1489633000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
290293000
CY2022Q3 snwv Accrued Registration Penalties Current
AccruedRegistrationPenaltiesCurrent
1593000
CY2021Q4 snwv Accrued Registration Penalties Current
AccruedRegistrationPenaltiesCurrent
1950000
CY2022Q3 snwv Accrued License Fees Current
AccruedLicenseFeesCurrent
893000
CY2021Q4 snwv Accrued License Fees Current
AccruedLicenseFeesCurrent
893000
CY2022Q3 snwv Accrued Board Of Director Fees Current
AccruedBoardOfDirectorFeesCurrent
663000
CY2021Q4 snwv Accrued Board Of Director Fees Current
AccruedBoardOfDirectorFeesCurrent
507000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
951000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1044000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4100000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4394000
CY2022Q3 snwv Debt Instrument Carrying Amount Current
DebtInstrumentCarryingAmountCurrent
-39823000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9746000
CY2022Q3 snwv Debt Instrument Remaining Embedded Conversion Option Current
DebtInstrumentRemainingEmbeddedConversionOptionCurrent
-1922000
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
31999000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25574000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5567000
CY2021Q4 snwv Debt Instrument Remaining Embedded Conversion Option
DebtInstrumentRemainingEmbeddedConversionOption
6255000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
26262000
CY2021Q4 snwv Debt Instrument Carrying Amount Current
DebtInstrumentCarryingAmountCurrent
24699000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
5567000
CY2021Q4 snwv Debt Instrument Remaining Embedded Conversion Option Current
DebtInstrumentRemainingEmbeddedConversionOptionCurrent
6255000
snwv Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
27946
snwv Class Of Warrant Or Right Weighted Average Exercise Price Of Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceOfExercised
0.01
snwv Class Of Warrant Or Right Issuances In Period
ClassOfWarrantOrRightIssuancesInPeriod
829554
snwv Class Of Warrant Or Right Weighted Average Exercise Price Of Issuances
ClassOfWarrantOrRightWeightedAverageExercisePriceOfIssuances
0.05
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
25387000
CY2021Q4 snwv Debt Instrument Carrying Amount Noncurrent
DebtInstrumentCarryingAmountNoncurrent
875000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0
CY2021Q4 snwv Debt Instrument Remaining Embedded Conversion Option Noncurrent
DebtInstrumentRemainingEmbeddedConversionOptionNoncurrent
0
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
875000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y6M14D
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1006491
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.08
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0

Files In Submission

Name View Source Status
0001140361-22-041447-index-headers.html Edgar Link pending
0001140361-22-041447-index.html Edgar Link pending
0001140361-22-041447.txt Edgar Link pending
0001140361-22-041447-xbrl.zip Edgar Link pending
brhc10043756_10q.htm Edgar Link pending
brhc10043756_ex31-1.htm Edgar Link pending
brhc10043756_ex31-2.htm Edgar Link pending
brhc10043756_ex32-1.htm Edgar Link pending
brhc10043756_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
brhc10043756_10q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snwv-20220930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
snwv-20220930_cal.xml Edgar Link unprocessable
snwv-20220930_def.xml Edgar Link unprocessable
snwv-20220930_lab.xml Edgar Link unprocessable
snwv-20220930_pre.xml Edgar Link unprocessable